Osmolex er and Gait disturbance - a phase IV clinical study of FDA data

Summary:

Gait disturbance is reported as a side effect among people who take Osmolex er (amantadine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neupro, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Gait disturbance when taking Osmolex er. It is created by eHealthMe based on reports of 782 people who have side effects when taking Osmolex er from the FDA, and is updated regularly.

What is Osmolex er?

Osmolex er has active ingredients of amantadine hydrochloride. eHealthMe is studying from 783 Osmolex er users. Check the latest studies of Osmolex er.

What is Gait disturbance?

Gait disturbance is found to be associated with 2,813 drugs and 3,667 conditions by eHealthMe. Check the latest studies of Gait disturbance.

On Jul, 16, 2026

782 people reported to have side effects when taking Osmolex er.
Among them, 21 people (2.69%) have Gait disturbance.

Could Osmolex er cause Gait disturbance?

Among these 21 people:

How long have people been on Osmolex er when they have Gait disturbance? *

What is the gender of people who have Gait disturbance when taking Osmolex er? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Gait disturbance when taking Osmolex er? *

What are other drugs people take besides Osmolex er? *

What are other side effects people have besides Gait disturbance? *

Drug Ineffective: 3 people, 14.29%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 14.29%
Dizziness: 2 people, 9.52%
Joint Pain: 2 people, 9.52%
Joint Stiffness: 2 people, 9.52%
Balance Disorder: 2 people, 9.52%
Stress And Anxiety: 2 people, 9.52%
Fall: 2 people, 9.52%
Constipation: 1 person, 4.76%
Drowsiness: 1 person, 4.76%

What are the existing conditions these people have? *

Parkinson's Disease: 18 people, 85.71%
Vitamin B Complex Deficiency: 1 person, 4.76%
High Blood Pressure: 1 person, 4.76%
Bipolar Disorder (mood disorder): 1 person, 4.76%
Cardiac Disorder: 1 person, 4.76%
Depression: 1 person, 4.76%
Drowsiness: 1 person, 4.76%
Emotional Distress: 1 person, 4.76%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 1 person, 4.76%
High Blood Cholesterol: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Osmolex er and have Gait disturbance?

- Check whether Gait disturbance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Osmolex er:

Osmolex er (783 reports)

Gait disturbance treatments and more:

Gait disturbance (245,673 reports)

Browse all side effects of Osmolex er:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gait disturbance:

Gait disturbance (2,813 drugs)

Browse all the conditions that are associated with Gait disturbance:

Gait disturbance (3,667 conditions)

Related publications that referenced our studies

Yang Y, Teja S, Baig K, "Bilateral corneal edema associated with amantadine", Canadian Medical Association Journal, 2015 Oct .
Cattoni J, Parekh R, "Acute respiratory distress syndrome: A rare presentation of amantadine toxicity", The American journal of case reports, 2012 Jan .
Yang Y, Teja S, Baig K, "Bilateral corneal edema associated with amantadine", Canadian Medical Association Journal, 2015 Oct .
Cattoni J, Parekh R, "Acute respiratory distress syndrome: A rare presentation of amantadine toxicity", The American journal of case reports, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on amantadine hydrochloride (the active ingredients of Osmolex er) and Osmolex er (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.